Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience [Breast Cancer]
Conclusion
In this large early-stage breast cancer cohort, MN risk after radiation and/or adjuvant chemotherapy was low but higher than previously described. Risk continued to increase beyond 5 years. Individual risk of MN must be balanced against the absolute survival benefit of adjuvant chemotherapy.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Wolff, Blackford, Visvanathan, Rugo, Moy, Goldstein, Stockerl-Goldstein, Neumayer, Langbaum, Theriault, Hughes, Weeks, Karp Tags: Radiation, Chemotherapy, Combined Modality Breast Cancer Source Type: research
More News: Academia | Acute Leukemia | Acute Myeloid Leukemia | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Epidemiology | Leukemia | Myelodysplastic Syndrome